Ryan S. Lane
Affiliations: | Cell, Developmental, and Cancer Biology | Oregon Health and Science University, Portland, OR |
Google:
"Ryan Lane"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Castiglioni A, Yang Y, Williams K, et al. (2023) Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors. Nature Communications. 14: 4703 |
| Ngamcherdtrakul W, Reda M, Nelson MA, et al. (2021) In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response. Advanced Materials (Deerfield Beach, Fla.). e2100628 |
| Kapoor VN, Müller S, Keerthivasan S, et al. (2021) Gremlin 1 fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues. Nature Immunology |
| Lane RS, Breazeale AP, Lund AW. (2020) Abstract A78: IFNg-activated lymphatic vessels express PD-L1 and suppress effector T-cell function in melanoma Cancer Immunology Research. 8 |
| Steele MM, Churchill MJ, Breazeale AP, et al. (2019) Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors. Journal of Visualized Experiments : Jove |
| Lane RS, Lund AW. (2018) Non-hematopoietic Control of Peripheral Tissue T Cell Responses: Implications for Solid Tumors. Frontiers in Immunology. 9: 2662 |
| Lane RS, Femel J, Breazeale AP, et al. (2018) IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. The Journal of Experimental Medicine |
| Loo CP, Nelson NA, Lane RS, et al. (2017) Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection. Cell Reports. 20: 3176-3187 |
| Lane RS, Femel J, Booth J, et al. (2017) Abstract NG02: Lymphatic vessels: Balancing immune priming and immune evasion in melanoma Immunology. 77 |
| Ager C, Reilley M, Nicholas C, et al. (2016) 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4 |